STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [Form 4] CoreWeave, Inc. Insider Trading Activity

CoreWeave (CRWV) CFO details RSU vesting and tax-driven share sale

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

CoreWeave, Inc.’s chief financial officer reported an RSU vesting and related share sale. On December 11, 2025, 122,340 restricted stock units converted into the same number of shares of Class A common stock. To satisfy tax withholding obligations tied to this vesting and settlement, the officer sold 66,467 shares at a weighted average price of $82.5753, with individual trades ranging from $82.48 to $82.58.

After these transactions, the officer directly holds 203,392 Class A shares, plus 115,905 shares held by a spouse and 57,952 shares held through the Yosemite 2025 GRAT. The officer also continues to hold 1,100,980 restricted stock units, which vest in roughly 1/16 increments on the eleventh day of June, September, December, and March, subject to continued service, and either vest or are cancelled rather than expiring.

Positive

  • None.

Negative

  • None.
Insider Agrawal Nitin
Role Chief Financial Officer
Sold 66,467 shs ($5.49M)
Type Security Shares Price Value
Exercise Restricted Stock Units 122,340 $0.00 --
Exercise Class A Common Stock 122,340 $0.00 --
Sale Class A Common Stock 66,467 $82.5753 $5.49M
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 1,100,980 shares (Direct); Class A Common Stock — 269,859 shares (Direct); Class A Common Stock — 115,905 shares (Indirect, By Spouse)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.48 to $82.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing. The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. The award vested or vests ratably as to approximately 1/16 of the total award on the eleventh calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vested on June 11, 2024. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Agrawal Nitin
(Last) (First) (Middle)
C/O COREWEAVE, INC.
290 WEST MT. PLEASANT AVENUE, SUITE 4100
(Street)
LIVINGSTON NJ 07039
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/11/2025 M 122,340 A (1) 269,859 D
Class A Common Stock 12/11/2025 S(2) 66,467 D $82.5753(3) 203,392 D
Class A Common Stock 115,905 I By Spouse
Class A Common Stock 57,952 I By Yosemite 2025 GRAT(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 12/11/2025 M 122,340 (5) (6) Class A Common Stock 122,340 (1) 1,100,980 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
2. The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.48 to $82.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
4. The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
5. The award vested or vests ratably as to approximately 1/16 of the total award on the eleventh calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vested on June 11, 2024.
6. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
/s/ Nisha Antony, as Attorney-in-Fact 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CoreWeave (CRWV) disclose for its CFO?

CoreWeave reported that its chief financial officer had 122,340 restricted stock units convert into Class A common stock and sold 66,467 shares to cover tax withholding obligations related to that vesting.

How many CoreWeave Class A shares vested for the CFO on December 11, 2025?

On December 11, 2025, 122,340 restricted stock units vested and settled into 122,340 shares of CoreWeave Class A common stock.

How many CoreWeave shares did the CFO sell and at what price?

The CFO sold 66,467 shares of Class A common stock at a weighted average price of $82.5753 per share, with individual trades executed between $82.48 and $82.58, to satisfy tax withholding obligations.

What are the CoreWeave CFO's shareholdings after these transactions?

Following the reported transactions, the CFO directly owns 203,392 Class A shares. In addition, 115,905 shares are held by the officer’s spouse and 57,952 shares are held through the Yosemite 2025 GRAT, and the officer holds 1,100,980 restricted stock units.

What is the vesting schedule for the CoreWeave RSU award reported by the CFO?

The RSU award vests in approximately 1/16 increments on the eleventh calendar day of June, September, December, and March, subject to the CFO’s continued service, with the first tranche having vested on June 11, 2024.

Do the reported CoreWeave restricted stock units have an expiration date?

No. The filing states that these restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

What is the Yosemite 2025 GRAT mentioned in the CoreWeave insider filing?

The Yosemite 2025 GRAT is a grantor retained annuity trust that directly holds 57,952 shares of CoreWeave Class A common stock, and the CFO is described as the sole trustee and beneficiary of this trust.